Microneedle Patch Boosts Heart Attack Recovery
- A new biodegradable patch, utilizing microneedle technology to deliver targeted immune support, shows promise in repairing heart damage after a heart attack.
- heart attacks cause significant damage to cardiac muscle, often leading to long-term complications like heart failure.
- Ke Huang at Texas A&M University has created a patch designed to support heart repair following a heart attack.
“`html
Texas A&M researchers Develop Minimally Invasive Heart Repair Patch
Table of Contents
A new biodegradable patch, utilizing microneedle technology to deliver targeted immune support, shows promise in repairing heart damage after a heart attack. Researchers are working towards less invasive delivery methods.
The Challenge of Heart Attack Recovery
heart attacks cause significant damage to cardiac muscle, often leading to long-term complications like heart failure. Current treatments focus on restoring blood flow, but promoting actual tissue regeneration remains a major challenge. According to the Centers for Disease Control and Prevention, heart disease is the leading cause of death for both men and women in the United States.
How the Patch Works
A research team led by dr. Ke Huang at Texas A&M University has created a patch designed to support heart repair following a heart attack. This device uses a specialized microneedle system that delivers a therapeutic molecule directly into damaged heart tissue, encouraging healing while limiting effects on the rest of the body. The biodegradable patch contains extremely small needles filled with microscopic particles carrying interleukin-4 (IL-4), a molecule recognized for its role in immune regulation. When placed on the heart’s surface, the microneedles dissolve and release IL-4 straight into the injured region, helping create conditions that support recovery.
“This patch acts like a bridge,” saeid Huang, assistant professor in the Department of Pharmaceutical Sciences. “The microneedles deliver the IL-4 directly to the damaged area, modulating the immune response and encouraging the heart to heal itself.”
Research and Funding
Huang and his colleagues reported their results in cell Biomaterials on November 16,2023,with funding from the National Institutes of Health and the American Heart Association. The study details the patch’s ability to reduce scar tissue formation and improve cardiac function in preclinical models.
The research builds on a growing understanding of the role of the immune system in cardiac repair. IL-4 is a cytokine known to promote a specific type of immune response that can be beneficial for tissue regeneration, but systemic management can have unwanted side effects. The microneedle patch allows for localized delivery, maximizing therapeutic benefit while minimizing systemic exposure.
Moving Towards Minimally Invasive Delivery
At the moment, placing the patch requires open-chest surgery, but Huang hopes to create a less invasive method. He imagines a design that could be delivered through a small tube, making the treatment easier and more practical in clinical settings.
“This is just the beginning,” he said. “We’ve proven the concept. Now we want to optimize the design and delivery.”
Huang is now partnering with Xiaoqing (Jade) Wang, assistant professor of statistics in the College of Arts and Sciences.Together they are developing an AI model that maps immune responses and helps guide future immunomodulatory therapeutic delivery.